Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEMOLIZUMAB-ILTO: 4,183 Adverse Event Reports & Safety Profile

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra
4,183
Total FAERS Reports
32 (0.8%)
Deaths Reported
115
Hospitalizations
4,183
As Primary/Secondary Suspect
1
Life-Threatening
4
Disabilities
Prescription
Status

FDA Application: 761390 ·

First Report: 20180101 · Latest Report: 22050101

What Are the Most Common NEMOLIZUMAB-ILTO Side Effects?

#1 Most Reported
Inappropriate schedule of product administration
826 reports (19.7%)
#2 Most Reported
Product dose omission issue
792 reports (18.9%)
#3 Most Reported
Device malfunction
761 reports (18.2%)

All NEMOLIZUMAB-ILTO Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Inappropriate schedule of product administration 826 19.8% 0 7
Product dose omission issue 792 18.9% 0 12
Device malfunction 761 18.2% 0 1
Incorrect dose administered 579 13.8% 0 1
Pruritus 416 10.0% 0 9
Rash 263 6.3% 1 5
Headache 181 4.3% 0 3
Drug ineffective 158 3.8% 0 2
Device leakage 153 3.7% 0 1
Device use issue 120 2.9% 0 0
Dermatitis atopic 117 2.8% 0 0
Neurodermatitis 109 2.6% 0 2
Eczema 108 2.6% 0 0
Dry skin 105 2.5% 0 1
Erythema 88 2.1% 0 5
Intentional product use issue 88 2.1% 0 2
Skin exfoliation 82 2.0% 0 4
Arthralgia 77 1.8% 0 1
Urticaria 77 1.8% 0 2
Rash papular 68 1.6% 0 4

Who Reports NEMOLIZUMAB-ILTO Side Effects? Age & Gender Data

Gender: 73.1% female, 26.9% male. Average age: 53.4 years. Most reports from: US. View detailed demographics →

Is NEMOLIZUMAB-ILTO Getting Safer? Reports by Year

YearReportsDeathsHosp.
2018 1 0 0
2020 1 0 0
2023 1 0 0
2024 235 0 8
2025 2,271 26 57

View full timeline →

What Is NEMOLIZUMAB-ILTO Used For?

IndicationReports
Neurodermatitis 1,765
Dermatitis atopic 1,596
Product used for unknown indication 658
Eczema 99
Pruritus 30
Psoriasis 11
Dermatitis 7
Rash 5
Urticaria 5

NEMOLIZUMAB-ILTO vs Alternatives: Which Is Safer?

NEMOLIZUMAB-ILTO vs NEOMYCIN NEMOLIZUMAB-ILTO vs NEORAL NEMOLIZUMAB-ILTO vs NEOSTIGMINE NEMOLIZUMAB-ILTO vs NEOSTIGMINE METHYLSULFATE NEMOLIZUMAB-ILTO vs NEPAFENAC NEMOLIZUMAB-ILTO vs NERATINIB NEMOLIZUMAB-ILTO vs NETARSUDIL NEMOLIZUMAB-ILTO vs NETUPITANT\PALONOSETRON NEMOLIZUMAB-ILTO vs NEULASTA NEMOLIZUMAB-ILTO vs NEUPOGEN

Official FDA Label for NEMOLIZUMAB-ILTO

Official prescribing information from the FDA-approved drug label.